NeuroBo Pharmaceuticals (NRBO) Stock Chart & Stock Price History → He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad) Free NRBO Stock Alerts $3.96 -0.04 (-1.00%) (As of 05/10/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media NeuroBo Pharmaceuticals Stock Price Performance5 Day Performance+3.13%1 Month Performance+9.70%3 Month Performance-20.80%6 Month Performance+15.09%Year-To-Date Performance+7.13%1 Year Performance-13.90% Receive NRBO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NeuroBo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. NRBO Stock Chart for Sunday, May, 12, 2024 NRBO Chart by TradingView NeuroBo Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/10/2024$4.00$3.96-0.88%$4.00$3.9015,915 shs$19.43 million05/09/2024$3.93$4.00+1.65%$4.06$3.8535,344 shs$19.62 million05/08/2024$3.84$3.93+2.34%$4.00$3.8419,408 shs$19.30 million05/07/2024$3.80$3.84+1.05%$4.03$3.7037,723 shs$18.85 million05/06/2024$3.78$3.80+0.53%$3.93$3.7012,823 shs$18.66 million05/03/2024$3.73$3.78+1.34%$3.80$3.6022,109 shs$18.56 million Get the Latest News and Ratings for NRBO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NeuroBo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/02/2024$3.68$3.73+1.36%$3.73$3.5514,904 shs$18.31 million05/01/2024$3.30$3.68+11.52%$3.68$3.3560,029 shs$18.07 million04/30/2024$3.23$3.30+2.17%$3.40$3.2542,189 shs$16.20 million04/29/2024$3.14$3.23+2.87%$3.23$3.1012,214 shs$15.86 million04/26/2024$3.06$3.10+1.31%$3.10$3.0117,307 shs$15.22 million04/25/2024$3.10$3.06-1.29%$3.16$3.031,823 shs$15.01 million04/24/2024$3.02$3.10+2.65%$3.50$2.9939,253 shs$15.22 million04/23/2024$3.12$3.02-3.21%$3.19$2.9942,194 shs$14.83 million04/22/2024$3.37$3.12-7.42%$3.27$3.0823,389 shs$15.32 million04/19/2024$3.40$3.37-0.88%$3.49$3.2620,537 shs$16.55 million04/18/2024$3.46$3.40-1.73%$3.63$3.3522,788 shs$16.69 million04/17/2024$3.40$3.46+1.76%$3.69$3.4611,485 shs$16.99 million04/16/2024$3.53$3.40-3.68%$3.62$3.3312,910 shs$16.69 million04/15/2024$3.61$3.53-2.22%$3.73$3.4922,867 shs$17.33 million04/12/2024$3.58$3.61+0.84%$3.95$3.5875,302 shs$17.73 million04/11/2024$3.56$3.58+0.56%$3.69$3.5614,698 shs$17.56 million04/10/2024$3.53$3.56+0.85%$3.66$3.5013,047 shs$17.48 million04/09/2024$3.97$3.53-11.08%$3.93$3.4747,503 shs$17.33 million04/08/2024$3.88$3.97+2.32%$3.97$3.7713,359 shs$19.49 million04/05/2024$3.89$3.88-0.26%$3.94$3.7524,656 shs$19.05 million04/04/2024$3.89$3.89$4.04$3.8224,739 shs$19.10 million04/03/2024$3.93$3.89-1.02%$4.07$3.8013,935 shs$19.10 million04/02/2024$4.06$3.93-3.20%$4.12$3.8527,715 shs$19.06 million04/01/2024$4.09$4.06-0.73%$4.16$3.8049,882 shs$19.70 million03/29/2024$4.09$4.09$4.39$4.0735,570 shs$19.84 million03/28/2024$4.34$4.09-5.76%$4.39$4.0734,044 shs$19.84 million03/27/2024$4.30$4.34+0.93%$4.57$4.1721,612 shs$21.05 million03/26/2024$4.39$4.30-1.94%$4.38$4.2273,948 shs$20.86 million03/25/2024$4.46$4.39-1.68%$4.60$4.3450,797 shs$21.27 million03/22/2024$4.58$4.46-2.62%$4.73$4.4022,616 shs$21.63 million03/21/2024$4.39$4.58+4.33%$4.67$4.3967,872 shs$22.21 million03/20/2024$4.11$4.39+6.81%$4.44$4.1440,291 shs$21.29 million03/19/2024$4.34$4.11-5.30%$4.40$4.1168,991 shs$19.93 million03/18/2024$4.60$4.34-5.65%$4.65$4.3236,590 shs$21.05 millionGold Mania (Ad)Former Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).See his free reveal right here.03/15/2024$4.55$4.60+1.10%$4.72$4.5431,075 shs$22.31 million03/14/2024$4.47$4.55+1.79%$4.71$4.3848,003 shs$22.07 million03/13/2024$4.87$4.47-8.21%$5.05$4.34314,434 shs$21.68 million03/12/2024$5.12$4.87-4.88%$5.28$4.7652,195 shs$23.63 million03/11/2024$5.36$5.12-4.48%$5.53$5.1143,095 shs$24.83 million03/08/2024$5.46$5.36-1.83%$5.65$5.3630,464 shs$26.00 million03/07/2024$5.61$5.46-2.67%$5.71$5.35113,303 shs$27.22 million03/06/2024$6.29$5.61-10.81%$6.29$5.55140,365 shs$27.21 million03/05/2024$6.52$6.29-3.53%$6.68$6.1483,520 shs$30.51 million03/04/2024$6.24$6.52+4.49%$6.75$6.06261,398 shs$31.62 million03/01/2024$5.79$6.24+7.77%$6.34$5.52407,225 shs$30.26 million02/29/2024$5.12$5.79+13.09%$5.97$5.153.33 million shs$28.08 million02/28/2024$4.81$5.12+6.44%$5.30$4.8560,237 shs$24.83 million02/27/2024$5.59$4.81-13.95%$5.66$4.76103,778 shs$23.34 million02/26/2024$5.30$5.59+5.47%$5.61$5.3582,136 shs$27.11 million02/23/2024$5.73$5.30-7.57%$5.85$5.2063,371 shs$25.71 million02/22/2024$5.82$5.73-1.48%$5.86$5.5083,758 shs$27.82 million02/21/2024$5.35$5.82+8.79%$5.84$5.27123,318 shs$28.23 million02/20/2024$5.27$5.35+1.52%$5.39$4.9260,378 shs$25.95 million02/19/2024$5.27$5.27$5.30$4.74118,900 shs$25.56 million02/16/2024$4.83$5.27+9.11%$5.30$4.74118,662 shs$25.56 million02/15/2024$4.77$4.83+1.26%$4.96$4.6927,776 shs$23.43 million02/14/2024$4.93$4.77-3.25%$4.94$4.6358,658 shs$23.13 million02/13/2024$5.00$4.93-1.40%$5.05$4.7635,740 shs$23.91 million02/12/2024$4.56$5.00+9.65%$5.10$4.44169,324 shs$24.26 million Related Companies: Flora Growth Stock Price Chart Galecto Stock Price Chart Aptorum Group Stock Price Chart BioVie Stock Price Chart Orgenesis Stock Price Chart KALA BIO Stock Price Chart GlycoMimetics Stock Price Chart NanoViricides Stock Price Chart NeuroSense Therapeutics Stock Price Chart Indaptus Therapeutics Stock Price Chart Receive NRBO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NeuroBo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NRBO) was last updated on 5/12/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaShocking: One AI startup's revenue could surge 4,735%Manward PressMissed NVDA? Buy this AI stock NOWChaikin Analytics[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICYou need to know these two things about AI stocks ASAP…InvestorPlaceCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingElon to Transform U.S. Economy? Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroBo Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.